Lactobacillus rhamnosus GG and Streptococcus thermophilus induce suppressor of cytokine signalling 3 (SOCS3) gene expression directly and indirectly via interleukin-10 in human primary macrophages

Clinical and Experimental Immunology

Volumn 165, Issue 1, 2011, Pages 94-103

  Latvala, S ^a   Miettinen, M ^b   Kekkonen, R A ^b   Korpela, R ^c   Julkunen, I ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b VALIO LTD   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cytokine; Gene regulation; Innate immunity; Leucocyte; Signal transduction

Indexed keywords

CYCLOHEXIMIDE; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 12; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ARTICLE; BIFIDOBACTERIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; FOOD INDUSTRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; LACTOBACILLUS RHAMNOSUS; LACTOCOCCUS; LEUCONOSTOC; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RNA ISOLATION; SIGNAL TRANSDUCTION; STREPTOCOCCUS; STREPTOCOCCUS THERMOPHILUS; TH1 CELL; TH1 TH2 BALANCE; TH2 CELL;

CELL CULTURE TECHNIQUES; CELLS, CULTURED; GENE EXPRESSION REGULATION; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; IMMUNOMODULATION; INTERLEUKIN-10; INTERLEUKIN-12; LACTOBACILLUS RHAMNOSUS; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; PROBIOTICS; SPECIES SPECIFICITY; STREPTOCOCCUS THERMOPHILUS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 79958136845     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04408.x     Document Type: Article

References (46)

1. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5:953-64.
2. Stout RD, Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 2004; 76:509-13.
3. Akira S. Mammalian Toll-like receptors. Curr Opin Immunol 2003; 15:5-11.
4. Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 2009; 22:240-73.
5. Dimitriou ID, Clemenza L, Scotter AJ, Chen G, Guerra FM, Rottapel R. Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins. Immunol Rev 2008; 224:265-83.
6. Alexander WS. Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2002; 2:410-16.
7. Lenoir-Wijnkoop I, Sanders ME, Cabana MD etal. Probiotic and prebiotic influence beyond the intestinal tract. Nutr Rev 2007; 65:469-89.
8. Arvola T, Laiho K, Torkkeli S etal. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999; 104:e64.
9. Szajewska H, Kotowska M, Mrukowicz JZ, Armanska M, Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 2001; 138:361-5.
10. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30:1604-10.
11. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361:1869-71.
12. Schultz M, Linde HJ, Lehn N etal. Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers. J Dairy Res 2003; 70:165-73.
13. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99:179-85.
14. Kajander K, Hatakka K, Poussa T, Farkkila M, Korpela R. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther 2005; 22:387-94.
15. Myllyluoma E, Veijola L, Ahlroos T etal. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy - a placebo-controlled, double-blind randomized pilot study. Aliment Pharmacol Ther 2005; 21:1263-72.
16. Staaf M, Yang Z, Huttunen E, Widmalm G. Structural elucidation of the viscous exopolysaccharide produced by Lactobacillus helveticus Lb161. Carbohydr Res 2000; 326:113-19.
17. Yang Z, Staaf M, Huttunen E, Widmalm G. Structure of a viscous exopolysaccharide produced by Lactobacillus helveticus K16. Carbohydr Res 2000; 329:465-9.
18. Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 1995; 78:491-7.
19. Kekkonen RA, Kajasto E, Miettinen M, Veckman V, Korpela R, Julkunen I. Probiotic Leuconostoc mesenteroides ssp. cremoris and Streptococcus thermophilus induce IL-12 and IFN-gamma production. World J Gastroenterol 2008; 14:1192-203.
20. Yang Z, Huttunen H, Staaf M, Widmalm G, Tenhu H. Separation, purification and characterization of extracellular polysaccharides produced by slime-forming Lactococcus lactis ssp. cremoris strains. Int Dairy J 1999; 9:631-8.
21. Nordmark EL, Yang Z, Huttunen E, Widmalm G. Structural studies of an exopolysaccharide produced by Streptococcus thermophilus THS. Biomacromolecules 2005; 6:105-8.
22. Miettinen M, Lehtonen A, Julkunen I, Matikainen S. Lactobacilli and Streptococci activate NF-kappa B and STAT signaling pathways in human macrophages. J Immunol 2000; 164:3733-40.
23. Latvala S, Pietila TE, Veckman V etal. Potentially probiotic bacteria induce efficient maturation but differential cytokine production in human monocyte-derived dendritic cells. World J Gastroenterol 2008; 14:5570-83.
24. Miettinen M, Vuopio-Varkila J, Varkila K. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect Immun 1996; 64:5403-5.
25. Miettinen M, Veckman V, Latvala S, Sareneva T, Matikainen S, Julkunen I. Live Lactobacillus rhamnosus and Streptococcus pyogenes differentially regulate Toll-like receptor (TLR) gene expression in human primary macrophages. J Leukoc Biol 2008; 84:1092-100.
26. Kim SO, Sheikh HI, Ha SD, Martins A, Reid G. G-CSF-mediated inhibition of JNK is a key mechanism for Lactobacillus rhamnosus-induced suppression of TNF production in macrophages. Cell Microbiol 2006; 8:1958-71.
27. Mohamadzadeh M, Klaenhammer TR. Specific Lactobacillus species differentially activate Toll-like receptors and downstream signals in dendritic cells. Exp Rev Vaccines 2008; 7:1155-64.
28. O'Hara AM, O'Regan P, Fanning A etal. Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 2006; 118:202-15.
29. Pietila TE, Veckman V, Kyllonen P, Lahteenmaki K, Korhonen TK, Julkunen I. Activation, cytokine production, and intracellular survival of bacteria in Salmonella-infected human monocyte-derived macrophages and dendritic cells. J Leukoc Biol 2005; 78:909-20.
30. Veckman V, Miettinen M, Pirhonen J, Siren J, Matikainen S, Julkunen I. Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1-type cytokines and chemokines in human monocyte-derived dendritic cells. J Leukoc Biol 2004; 75:764-71.
31. Lee JS, Paek NS, Kwon OS, Hahm KB. Anti-inflammatory actions of probiotics through activating suppressor of cytokine signaling (SOCS) expression and signaling in Helicobacter pylori infection: a novel mechanism. J Gastroenterol Hepatol 2010; 25:194-202.
32. Veckman V, Miettinen M, Matikainen S etal. Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th1 cell chemotaxis. J Leukoc Biol 2003; 74:395-402.
33. Niers LE, Timmerman HM, Rijkers GT etal. Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy 2005; 35:1481-9.
34. Foligne B, Nutten S, Grangette C etal. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol 2007; 13:236-43.
35. O'Mahony L, McCarthy J, Kelly P etal. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128:541-51.
36. Niemand C, Nimmesgern A, Haan S etal. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. J Immunol 2003; 170:3263-72.
37. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991; 174:1549-55.
38. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993; 178:1041-8.
39. Skeen MJ, Miller MA, Shinnick TM, Ziegler HK. Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. J Immunol 1996; 156:1196-206.
40. Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002; 168:171-8.
41. Hart AL, Lammers K, Brigidi P etal. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004; 53:1602-9.
42. Kekkonen RA, Lummela N, Karjalainen H etal. Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults. World J Gastroenterol 2008; 14:2029-36.
43. Cassatella MA, Gasperini S, Bovolenta C etal. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation. Blood 1999; 94:2880-9.
44. Ito S, Ansari P, Sakatsume M etal. Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by suppressing tyrosine phosphorylation of STAT1. Blood 1999; 93:1456-63.
45. Williams L, Bradley L, Smith A, Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol 2004; 172:567-76.
46. Kaji R, Kiyoshima-Shibata J, Nagaoka M, Nanno M, Shida K. Bacterial teichoic acids reverse predominant IL-12 production induced by certain lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages. J Immunol 2010; 184:3505-13.